Jetzt neu! Crypto CFDs von Plus500 auf Axie Infinity, Chainlink, Uniswap & Filecoin. Jetzt in der Demo kostenlos ausprobieren!*-w-
17.05.2022 21:52:17

Why BioNTech Stock Jumped Today

Shares of BioNTech (NASDAQ: BNTX) were up by 5.6% as of 3:24 p.m. ET Tuesday. The gain came after the Food and Drug Administration (FDA) expanded the Emergency Use Authorization (EUA) for the COVID-19 vaccine developed by Pfizer (NYSE: PFE) and BioNTech to include booster doses for 5- through 11-year-olds.So far, more than 8 million children in that age range have received a primary two-dose series of the Pfizer-BioNTech COVID-19 vaccine, now being marketed as Comirnaty. The expanded EUA allows these children to receive a booster dose as soon as five months after receiving the second dose in the primary series.This FDA decision probably won't result in any near-term financial impact for BioNTech. The federal government already has a supply deal in place with Pfizer and BioNTech for 600 million doses of the companies' COVID-19 vaccine. Around 432 million of those doses have been delivered thus far.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Analysen zu BioNTech (ADRs)mehr Analysen

01.07.22 BioNTech Hold Deutsche Bank AG
30.06.22 BioNTech Neutral UBS AG
30.06.22 BioNTech Neutral Goldman Sachs Group Inc.
15.06.22 BioNTech Neutral Goldman Sachs Group Inc.
11.05.22 BioNTech Neutral Goldman Sachs Group Inc.

Eintrag hinzufügen

Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

BioNTech (ADRs) 155,95 -0,16% BioNTech (ADRs)
pagehit